Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerAI sign LanguageOpen
VIPCreated with Sketch.

Short-Term Outcomes of Infants and Children Receiving Selexipag for Pulmonary Hypertension

J. Bullock,P. Chau, L. Wood,M.J. Bock

JOURNAL OF HEART AND LUNG TRANSPLANTATION（2020）

Cited 0|Views9
No score
Abstract
Administration of selexipag in infants and children appears safe, and is a viable alternative to other forms of prostacyclin administration in stable patients. Selexipag may also have a role as tertiary adjunct therapy for those who do not improve on dual oral therapy.
More
Translated text
Key words
selexipag,pulmonary hypertension,infants,short-term
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined